JPWO2020245264A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020245264A5 JPWO2020245264A5 JP2021571915A JP2021571915A JPWO2020245264A5 JP WO2020245264 A5 JPWO2020245264 A5 JP WO2020245264A5 JP 2021571915 A JP2021571915 A JP 2021571915A JP 2021571915 A JP2021571915 A JP 2021571915A JP WO2020245264 A5 JPWO2020245264 A5 JP WO2020245264A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cancer
- composition
- polynucleotide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025170954A JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1908012.6A GB201908012D0 (en) | 2019-06-05 | 2019-06-05 | TGF-Beta vaccine |
| GB1908012.6 | 2019-06-05 | ||
| PCT/EP2020/065472 WO2020245264A1 (en) | 2019-06-05 | 2020-06-04 | Tgf-beta vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Division JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022535102A JP2022535102A (ja) | 2022-08-04 |
| JP2022535102A5 JP2022535102A5 (https=) | 2023-06-14 |
| JPWO2020245264A5 true JPWO2020245264A5 (https=) | 2023-06-14 |
| JP7758573B2 JP7758573B2 (ja) | 2025-10-22 |
Family
ID=67385796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571915A Active JP7758573B2 (ja) | 2019-06-05 | 2020-06-04 | Ｔｇｆ－ベータワクチン |
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220315634A1 (https=) |
| EP (1) | EP3980449A1 (https=) |
| JP (2) | JP7758573B2 (https=) |
| KR (1) | KR20220018566A (https=) |
| CN (1) | CN113966342B (https=) |
| AU (2) | AU2020287902B9 (https=) |
| CA (1) | CA3141744A1 (https=) |
| GB (1) | GB201908012D0 (https=) |
| IL (1) | IL288673A (https=) |
| MX (1) | MX2021014856A (https=) |
| SG (1) | SG11202112416XA (https=) |
| WO (1) | WO2020245264A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022139493A1 (ko) * | 2020-12-23 | 2022-06-30 | 한국과학기술연구원 | TGF-β 신호전달을 억제할 수 있는 신규한 펩타이드 및 이의 용도 |
| WO2023161350A1 (en) | 2022-02-24 | 2023-08-31 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| CN119384291A (zh) * | 2022-05-18 | 2025-01-28 | 国立研究开发法人国立癌症研究中心 | 利用通用癌抗原鸡尾酒的癌症疫苗、tcr/car-t细胞治疗药、伴随诊断方法和基于血中循环癌细胞检测的癌症发病风险诊断方法 |
| GB202215997D0 (en) | 2022-10-28 | 2022-12-14 | Io Biotech Aps | Therapy |
| GB202216449D0 (en) | 2022-11-04 | 2022-12-21 | Io Biotech Aps | TGF-BETA1 vaccine |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| EP0877031A1 (en) * | 1997-05-06 | 1998-11-11 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1 |
| AU736207B2 (en) * | 1997-05-12 | 2001-07-26 | Kyowa Hakko Kogyo Co. Ltd. | Peptides which promote activation of latent TGF-beta and method of screening TGF-beta activity-regulating compounds |
| US6500920B1 (en) * | 1997-06-19 | 2002-12-31 | St. Louis University | Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor |
| WO2001072331A1 (en) * | 2000-03-31 | 2001-10-04 | Vaccine Chip Technology Aps | Immunostimulating properties of a fragment of tgf-beta |
| US8158589B2 (en) * | 2003-08-22 | 2012-04-17 | Proyecto Biomedicine Cima, S.L. | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) |
| WO2005105144A1 (ja) * | 2004-04-30 | 2005-11-10 | Kyowa Hakko Kogyo Co., Ltd. | 潜在型ＴＧＦ－βの活性化抑制剤 |
| WO2007048857A1 (es) * | 2005-10-24 | 2007-05-03 | Proyecto De Biomedicina Cima, S.L. | USO DE PÉPTIDOS INHIBIDORES DE TGF- βl EN LA PREPARACIÓN DE UN AGENTE MODULADOR DE LA RESPUESTA INMUNE |
| EP2276833A4 (en) * | 2008-03-21 | 2011-06-29 | Brigham & Womens Hospital | MODULATION OF THE IMMUNE RESPONSE |
| AU2010277554B2 (en) * | 2009-07-30 | 2015-02-19 | Antisense Pharma Gmbh | Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system |
| CN103087173B (zh) * | 2013-01-16 | 2014-07-16 | 西安交通大学医学院第一附属医院 | 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用 |
| HRP20251426T1 (hr) * | 2013-05-06 | 2026-01-02 | Scholar Rock, Inc. | Sastavi i postupci za modulaciju faktora rasta |
| WO2015138628A1 (en) * | 2014-03-11 | 2015-09-17 | University Of Florida Research Foundation, Inc. | Use of aav-expressed m013 protein as an anti-inflammatory therapeutic |
-
2019
- 2019-06-05 GB GBGB1908012.6A patent/GB201908012D0/en not_active Ceased
-
2020
- 2020-06-04 KR KR1020227000403A patent/KR20220018566A/ko active Pending
- 2020-06-04 EP EP20731430.3A patent/EP3980449A1/en active Pending
- 2020-06-04 WO PCT/EP2020/065472 patent/WO2020245264A1/en not_active Ceased
- 2020-06-04 AU AU2020287902A patent/AU2020287902B9/en active Active
- 2020-06-04 US US17/616,382 patent/US20220315634A1/en active Pending
- 2020-06-04 JP JP2021571915A patent/JP7758573B2/ja active Active
- 2020-06-04 CA CA3141744A patent/CA3141744A1/en active Pending
- 2020-06-04 MX MX2021014856A patent/MX2021014856A/es unknown
- 2020-06-04 SG SG11202112416XA patent/SG11202112416XA/en unknown
- 2020-06-04 CN CN202080040978.4A patent/CN113966342B/zh active Active
-
2021
- 2021-12-05 IL IL288673A patent/IL288673A/en unknown
-
2025
- 2025-10-09 JP JP2025170954A patent/JP2026010046A/ja active Pending
-
2026
- 2026-01-16 AU AU2026200314A patent/AU2026200314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7871816B2 (en) | Vector for anti-HPV vaccine and transformed microorganism by the vector | |
| EP3094652B1 (en) | Novel vaccines against hpv and hpv-related diseases | |
| WO2003106682A1 (ja) | Ｈｌａ−ａ２４拘束性癌抗原ペプチド | |
| RU2007119319A (ru) | Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение | |
| JP2008530975A5 (https=) | ||
| EA016818B1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| JP2022507373A5 (https=) | ||
| US7247712B2 (en) | Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof | |
| JPWO2020245264A5 (https=) | ||
| JP2013047230A (ja) | Ｈｌａ−ａ２陽性者用ｈｓｐ１０５由来癌拒絶抗原ペプチド及びこれを含む医薬 | |
| CN105073989A (zh) | 免疫原性多肽表层表达双歧杆菌 | |
| CN1482916A (zh) | 含有转化生长因子α的疫苗组合物 | |
| JP2007511534A5 (https=) | ||
| US8207141B2 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| EP1719520B1 (en) | Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use | |
| JPWO2020099582A5 (https=) | ||
| JP2003522195A (ja) | 肝細胞癌の治療のための方法及び組成物 | |
| CN1793178A (zh) | 破伤风毒素t细胞表位多肽与人b淋巴细胞刺激因子融合蛋白及其制备 | |
| JP2003522157A (ja) | 癌およびその前段階に対する個体の免疫 | |
| ES2315405T3 (es) | Proteina pre-s del virus de la hepatitis b (vhb) como adyuvante y un componente de una vacuna frente a vhb. | |
| JPWO2020064744A5 (https=) | ||
| JP2002510496A (ja) | 細胞傷害性ｔ細胞を誘導するための医薬 | |
| CN106117334B (zh) | 一种肿瘤抗原mage3的ctl识别表位肽及其应用 | |
| JP2005513040A (ja) | Ｔｌｐペプチドを含む融合タンパク質 | |
| JP2005528100A (ja) | 免疫調節構築物およびその使用 |